| Year |
Title |
Altmetric |
| 2022
|
A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022).
Modern Pathology.
35:2023-2024.
2022
|
|
| 2022
|
Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification.
Modern Pathology.
35:1944-1954.
2022
|
|
| 2022
|
Ensuring remote diagnostics for pathologists: an open letter to the US Congress.
Nature Medicine.
28:2453-2455.
2022
|
|
| 2022
|
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer.
Archives of Pathology and Laboratory Medicine.
146:1194-1210.
2022
|
|
| 2022
|
Updates in 2022 on the staging of testicular germ cell tumors.
Human Pathology.
128:152-160.
2022
|
|
| 2022
|
Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series.
Modern Pathology.
35:1101-1109.
2022
|
|
| 2022
|
Single- versus multi-port robotic partial nephrectomy: a comparative analysis of perioperative outcomes and analgesic requirements.
Journal of Robotic Surgery.
16:695-703.
2022
|
|
| 2022
|
Granulomas associated with renal neoplasms: A multi-institutional clinicopathological study of 111 cases.
Histopathology.
80:922-927.
2022
|
|
| 2022
|
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases.
Modern Pathology.
35:344-351.
2022
|
|
| 2022
|
Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy.
Urologic Oncology: seminars and original investigations.
40:104.e1-104.e7.
2022
|
|
| 2022
|
Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6).
Modern Pathology.
35:289.
2022
|
|
| 2022
|
Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience.
Modern Pathology.
35:249-255.
2022
|
|
| 2022
|
Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
International Journal of Surgical Pathology.
2022
|
|
| 2021
|
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.
npj Precision Oncology.
5.
2021
|
|
| 2021
|
Vascular architectural patterns in clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma
2021
|
|
| 2021
|
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas.
Modern Pathology.
34:2055-2063.
2021
|
|
| 2021
|
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables.
Cells.
10.
2021
|
|
| 2021
|
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations.
Cells.
10.
2021
|
|
| 2021
|
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern Pathology.
34:1392-1424.
2021
|
|
| 2021
|
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia with New Reporting Recommendations and Approach to Lesions with Mixed and Early Patterns of Neoplasia.
Advances in Anatomic Pathology.
28:179-195.
2021
|
|
| 2021
|
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers.
Advances in Anatomic Pathology.
28:196-208.
2021
|
|
| 2021
|
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern Pathology.
34:1167-1184.
2021
|
|
| 2021
|
Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia (Modern Pathology, (2021), 10.1038/s41379-021-00737-6).
Modern Pathology.
34:1037.
2021
|
|
| 2021
|
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.
Urologic Oncology: seminars and original investigations.
39:295.e1-295.e8.
2021
|
|
| 2021
|
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.
Modern Pathology.
34:842-850.
2021
|
|
| 2021
|
The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer.
Archives of Pathology and Laboratory Medicine.
145:461-493.
2021
|
|
| 2021
|
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists.
Modern Pathology.
34:660-671.
2021
|
|
| 2021
|
GPS Assay association with long-term cancer outcomes: Twenty-year risk of distant metastasis and prostate cancer-specific mortality.
JCO Precision Oncology.
5:442-449.
2021
|
|
| 2021
|
A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI.
EBioMedicine.
63.
2021
|
|
| 2021
|
Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6).
Modern Pathology.
2021
|
|
| 2021
|
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations..
American Journal of Cancer Research.
11:3990-4001.
2021
|
|
| 2020
|
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
Modern Pathology.
33:2564-2579.
2020
|
|
| 2020
|
Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma with "Single-cell" Growth Reveals 2 Distinct Types, One with "Plasmacytoid" Features.
American Journal of Surgical Pathology.
44:1635-1642.
2020
|
|
| 2020
|
Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer with Multiparametric MRI.
American Journal of Roentgenology.
215:903-912.
2020
|
|
| 2020
|
Single-port robotic partial and radical nephrectomies for renal cortical tumors: initial clinical experience.
Journal of Robotic Surgery.
14:773-780.
2020
|
|
| 2020
|
Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment.
Prostate Cancer and Prostatic Diseases.
23:435-440.
2020
|
|
| 2020
|
Perioperative Outcomes of Single vs Multi-Port Robotic Assisted Radical Prostatectomy: A Single Institutional Experience.
Investigative urology.
204:490-495.
2020
|
|
| 2020
|
Reply by Authors.
Investigative urology.
204:495.
2020
|
|
| 2020
|
Reporting practices and resource utilization in the era of intraductal carcinoma of the prostate: A survey of genitourinary subspecialists.
American Journal of Surgical Pathology.
44:673-680.
2020
|
|
| 2020
|
Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.
Human Pathology.
98:81-88.
2020
|
|
| 2020
|
High-volume Concurrent Polypoid Ureteritis and Ureteritis Cystica Manifesting With Ureteral Obstruction.
Urology.
136:e7-e11.
2020
|
|
| 2019
|
Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis.
Clinical Genitourinary Cancer.
17:366-372.
2019
|
|
| 2019
|
Impact of cribriform pattern and intraductal carcinoma on Gleason 7 prostate cancer treated with external beam radiotherapy.
Investigative urology.
202:710-715.
2019
|
|
| 2019
|
Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.
European Radiology.
29:4861-4870.
2019
|
|
| 2019
|
Fumarát hydratáza deficientní karcinom z renálních buněk a jemu podobný karcinom z renálních buněk: Komparativní studie 23 geneticky testovaných případů.
Ceskoslovenska patologie.
55:244-249.
2019
|
|
| 2019
|
Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance.
Urology.
130:106-112.
2019
|
|
| 2019
|
Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.
Investigational New Drugs.
37:559-566.
2019
|
|
| 2019
|
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.
Oncogene.
38:4496-4511.
2019
|
|
| 2019
|
Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of “Recurrence”.
Clinical Genitourinary Cancer.
17:209-215.e1.
2019
|
|
| 2019
|
Clinical significance and EZH2, ERG and SPINK1 protein expression in pure and mixed ductal adenocarcinoma of the prostate
2019
|
|
| 2019
|
Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases.
Annals of Diagnostic Pathology.
39:63-68.
2019
|
|
| 2019
|
Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases..
Ceskoslovenska patologie.
55:244-249.
2019
|
|
| 2019
|
High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex.
Histopathology.
75:440-442.
2019
|
|
| 2019
|
Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) Identifies prognostic biomarkers and DLL3 as a relevant therapeutic target.
Clinical Cancer Research.
25:210-221.
2019
|
|
| 2018
|
"atrophic Kidney"-like Lesion.
American Journal of Surgical Pathology.
42:1585-1595.
2018
|
|
| 2018
|
Granular Cell Tumor of the Bladder: A Report of Six Cases.
Urology.
121:203.e1-203.e5.
2018
|
|
| 2018
|
IFNL4-ΔG allele is associated with an interferon signature in tumors and survival of African-American men with prostate cancer.
Clinical Cancer Research.
24:5471-5481.
2018
|
|
| 2018
|
Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
Advances in Anatomic Pathology.
25:387-399.
2018
|
|
| 2018
|
The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status.
Urology.
121:132-138.
2018
|
|
| 2018
|
Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): A multiinstitutional study of 40 cases with clinical follow-up.
American Journal of Surgical Pathology.
42:1156-1165.
2018
|
|
| 2018
|
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? A multi-center, multi-reader investigation.
Oncotarget.
9:33804-33817.
2018
|
|
| 2018
|
Unfavorable pathology, tissue biomarkers and genomic tests with clinical implications in prostate cancer management.
Advances in Anatomic Pathology.
25:293-303.
2018
|
|
| 2018
|
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.
Clinical Genitourinary Cancer.
16:e751-e760.
2018
|
|
| 2018
|
SWI/SNF protein expression status in fumarate hydratase–deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Human Pathology.
77:139-146.
2018
|
|
| 2018
|
Utility of Pathology Imagebase for standardisation of prostate cancer grading.
Histopathology.
73:8-18.
2018
|
|
| 2018
|
Eosinophilic solid and cystic renal cell carcinomas have metastatic potential.
Histopathology.
72:1066-1067.
2018
|
|
| 2018
|
Features and Prognostic Significance of Intraductal Carcinoma of the Prostate
2018
|
|
| 2018
|
Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases.
Histopathology.
72:777-785.
2018
|
|
| 2018
|
Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy.
Investigative urology.
199:719-725.
2018
|
|
| 2018
|
Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance.
Investigative urology.
199:438-444.
2018
|
|
| 2018
|
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.
Investigative urology.
199:445-452.
2018
|
|
| 2018
|
Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: Systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.
Modern Pathology.
31:179-197.
2018
|
|
| 2018
|
PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma with Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multi-institutional Study of 92 Cases.
Applied Immunohistochemistry and Molecular Morphology.
26:225-230.
2018
|
|
| 2018
|
Prostate cancer: diagnostic criteria and role of immunohistochemistry.
Modern Pathology.
31:12-21.
2018
|
|
| 2018
|
Reappraisal of Morphologic Differences between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
American Journal of Surgical Pathology.
42:279-292.
2018
|
|
| 2017
|
Erratum: Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer (eLife (2017) 6 PII: e33738).
eLife.
6.
2017
|
|
| 2017
|
Pathology Imagebase—a reference image database for standardization of pathology.
Histopathology.
71:677-685.
2017
|
|
| 2017
|
Direct metabolic interrogation of dihydrotestosterone biosynthesis from adrenal precursors in primary prostatectomy tissues.
Clinical Cancer Research.
23:6351-6363.
2017
|
|
| 2017
|
A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer.
eLife.
6.
2017
|
|
| 2017
|
Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma.
Annals of Diagnostic Pathology.
29:17-22.
2017
|
|
| 2017
|
Reporting and staging of testicular germ cell tumors: The international society of urological pathology (ISUP) testicular cancer consultation conference recommendations.
American Journal of Surgical Pathology.
41:e22-e32.
2017
|
|
| 2017
|
Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.
Bioconjugate Chemistry.
28:1031-1040.
2017
|
|
| 2017
|
Squamous cell carcinoma of the bladder complicating schistosomiasis
2017
|
|
| 2017
|
The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.
Histopathology.
70:513-521.
2017
|
|
| 2017
|
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
eLife.
6.
2017
|
|
| 2017
|
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.
Histopathology.
70:335-346.
2017
|
|
| 2017
|
Robot-assisted ureteral reconstruction using a tubularized peritoneal flap: a novel technique in a chronic porcine model.
World Journal of Urology.
35:89-96.
2017
|
|
| 2017
|
Small cell-like glandular proliferation of prostate: a rare lesion not related to small cell prostate cancer
2017
|
|
| 2017
|
Upper tract urothelial carcinomas: Frequency of association with mismatch repair protein loss and lynch syndrome.
Modern Pathology.
30:146-156.
2017
|
|
| 2016
|
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study
2016
|
|
| 2016
|
Tubulocystic carcinoma of the kidney with poorly differentiated foci.
American Journal of Surgical Pathology.
40:1457-1472.
2016
|
|
| 2016
|
Contemporary Gleason grading and novel Grade Groups in clinical practice.
Current Opinion in Urology.
26:488-492.
2016
|
|
| 2016
|
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
Histopathology.
69:441-449.
2016
|
|
| 2016
|
Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases from a Single Institution.
American Journal of Surgical Pathology.
40:1224-1231.
2016
|
|
| 2016
|
PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multiinstitutional Study of 92 Cases..
Applied Immunohistochemistry and Molecular Morphology.
2016
|
|
| 2016
|
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: Evidence for a biologically meaningful field effect.
Oncotarget.
7:33855-33865.
2016
|
|
| 2016
|
Malakoplakia associated with prostatic adenocarcinoma Report of 4 cases and literature review.
Annals of Diagnostic Pathology.
22:33-37.
2016
|
|
| 2016
|
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
Oncotarget.
7:29901-29915.
2016
|
|
| 2016
|
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer.
EBioMedicine.
7:85-93.
2016
|
|
| 2016
|
Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.
Urology.
90:148-152.
2016
|
|
| 2016
|
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
European Urology.
69:428-435.
2016
|
|
| 2016
|
Eosinophilic, solid, and cystic renal cell carcinoma.
American Journal of Surgical Pathology.
40:60-71.
2016
|
|
| 2016
|
Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome.
American Journal of Surgical Pathology.
40:865-875.
2016
|
|
| 2016
|
Renal cell carcinoma occurring in patients with prior neuroblastoma.
American Journal of Surgical Pathology.
40:989-997.
2016
|
|
| 2016
|
Renal neoplasms with overlapping features of clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma a clinicopathologic study of 37 cases from a single institution.
American Journal of Surgical Pathology.
40:141-154.
2016
|
|
| 2015
|
MicroRNA in prostate cancer: Practical aspects
2015
|
|
| 2015
|
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
European Urology.
68:555-567.
2015
|
|
| 2015
|
Diagnosis of "poorly formed glands" Gleason pattern 4 prostatic adenocarcinoma on needle biopsy: An interobserver reproducibility study among urologic pathologists with recommendations.
American Journal of Surgical Pathology.
39:1331-1339.
2015
|
|
| 2015
|
Handling and reporting of orchidectomy specimens with testicular cancer: Areas of consensus and variation among 25 experts and 225 European pathologists.
Histopathology.
67:313-324.
2015
|
|
| 2015
|
Novel biomarkers and genomic tests in prostate cancer: A critical analysis.
Minerva Urologica e Nefrologica.
67:211-231.
2015
|
|
| 2015
|
Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?.
BJU International.
116:220-229.
2015
|
|
| 2015
|
The TMPRSS2-ERG gene fusion blocks XRCC4-mediated nonhomologous end-joining repair and radiosensitizes prostate cancer cells to PARP inhibition.
Molecular Cancer Therapeutics.
14:1896-1906.
2015
|
|
| 2015
|
Biology of Human Tumors Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.
Clinical Cancer Research.
21:2591-2600.
2015
|
|
| 2015
|
EDB fibronectin specific peptide for prostate cancer targeting.
Bioconjugate Chemistry.
26:830-838.
2015
|
|
| 2015
|
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.
Modern Pathology.
28:612-630.
2015
|
|
| 2015
|
A genomic algorithm for the molecular classification of common renal cortical neoplasms: Development and validation.
Investigative urology.
193:1479-1485.
2015
|
|
| 2015
|
Metastatic prostate adenocarcinoma to the penis presenting as pagetoid carcinoma.
American Journal of Surgical Pathology.
39:724-726.
2015
|
|
| 2015
|
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
European Urology.
67:778-786.
2015
|
|
| 2015
|
Renal leiomyoma: A contemporary multi-institution study of an infrequent and frequently misclassified neoplasm.
American Journal of Surgical Pathology.
39:349-356.
2015
|
|
| 2015
|
Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from Intraductal Carcinoma of the Prostate on Needle Biopsy.
American Journal of Surgical Pathology.
39:169-178.
2015
|
|
| 2015
|
Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer.
Cell Reports.
13:2135-2146.
2015
|
|
| 2015
|
Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility.
CytoJournal.
12.
2015
|
|
| 2015
|
Urinary bladder xanthoma: A multi-institutional series of 17 cases.
Histopathology.
67:255-261.
2015
|
|
| 2014
|
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.
Investigative urology.
192:1081-1087.
2014
|
|
| 2014
|
Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
Molecular Cancer.
13.
2014
|
|
| 2014
|
A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
European Urology.
66:550-560.
2014
|
|
| 2014
|
Diagnostic criteria for ductal adenocarcinoma of the prostate: Interobserver variability among 20 expert uropathologists.
Histopathology.
65:216-227.
2014
|
|
| 2014
|
Epithelial-to-mesenchymal transition in renal neoplasms.
Advances in Anatomic Pathology.
21:174-180.
2014
|
|
| 2014
|
Intraductal carcinoma of the prostate: Interobserver reproducibility survey of 39 urologic pathologists.
Annals of Diagnostic Pathology.
18:333-342.
2014
|
|
| 2014
|
RNA biomarkers associated with metastatic progression in prostate cancer: A multi-institutional high-throughput analysis of SChLAP1
2014
|
|
| 2014
|
Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations.
Annales de Pathologie.
34:448-461.
2014
|
|
| 2014
|
Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: A clinicopathologic analysis of 76 cases with clinical follow-up.
American Journal of Surgical Pathology.
38:1260-1265.
2014
|
|
| 2014
|
Succinate dehydrogenase (SDH)-deficient renal carcinoma: A morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients.
American Journal of Surgical Pathology.
38:1588-1602.
2014
|
|
| 2014
|
Tuberous sclerosis-associated renal cell carcinoma: A clinicopathologic study of 57 separate carcinomas in 18 patients.
American Journal of Surgical Pathology.
38:1457-1467.
2014
|
|
| 2013
|
ERG protein expression as a biomarker of prostate cancer.
Biomarkers in Medicine.
7:851-865.
2013
|
|
| 2013
|
Prediction of prostate cancer to urethra distance by a pretreatment nomogram: Urethral thermoprotection implication in cryoablation.
Prostate Cancer and Prostatic Diseases.
16:372-375.
2013
|
|
| 2013
|
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies.
BMC Genomics.
14.
2013
|
|
| 2013
|
Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: A prospective cohort study.
Histopathology.
63:574-579.
2013
|
|
| 2013
|
Hereditary syndromes with associated renal neoplasia: A practical guide to histologic recognition in renal tumor resection specimens.
Advances in Anatomic Pathology.
20:245-263.
2013
|
|
| 2013
|
Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart
2013
|
|
| 2013
|
Metanephric adenoma and solid variant of papillary renal cell carcinoma: Common and distinctive features.
Histopathology.
62:941-953.
2013
|
|
| 2013
|
A 45-year-old with neuroendocrine carcinoma of the prostate.
Urology.
81:714-716.
2013
|
|
| 2013
|
Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer?
2013
|
|
| 2013
|
Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.
Cancer Research.
73:1211-1218.
2013
|
|
| 2013
|
Handling and staging of renal cell carcinoma: The International Society of Urological Pathology Consensus (ISUP) conference recommendations.
American Journal of Surgical Pathology.
37:1505-1517.
2013
|
|
| 2013
|
Metastatic papillary thyroid carcinoma to the kidney: Report of two cases mimicking primary renal cell carcinoma and review of the literature.
Pathology.
45:89-93.
2013
|
|
| 2013
|
Renal tumors: Diagnostic and prognostic biomarkers.
American Journal of Surgical Pathology.
37:1518-1531.
2013
|
|
| 2013
|
Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: A feasibility study.
Urology.
81:451-457.
2013
|
|
| 2013
|
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia.
American Journal of Surgical Pathology.
37:1469-1489.
2013
|
|
| 2013
|
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
American Journal of Surgical Pathology.
37:1490-1504.
2013
|
|
| 2012
|
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent.
Science.
338:1465-1469.
2012
|
|
| 2012
|
ERG protein expression in human tumors detected with a rabbit monoclonal antibody.
American Journal of Clinical Pathology.
138:803-810.
2012
|
|
| 2012
|
Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): Lack of utility to stratify cancer risks associated with HGPIN.
BJU International.
110.
2012
|
|
| 2012
|
Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy
2012
|
|
| 2012
|
A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimens.
European Urology.
62:20-39.
2012
|
|
| 2012
|
High-Grade prostatic intraepithelial neoplasia.
Investigative and Clinical Urology.
53:297-303.
2012
|
|
| 2012
|
Intraductal carcinoma of the prostate.
Archives of Pathology and Laboratory Medicine.
136:418-425.
2012
|
|
| 2011
|
Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
Modern Pathology.
24:1521-1529.
2011
|
|
| 2011
|
ERG gene rearrangement status in prostate cancer detected by immunohistochemistry
2011
|
|
| 2011
|
PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.
American Journal of Surgical Pathology.
35:1473-1483.
2011
|
|
| 2011
|
Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
American Journal of Surgical Pathology.
35:1134-1139.
2011
|
|
| 2011
|
International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens.
Advances in Anatomic Pathology.
18:301-305.
2011
|
|
| 2011
|
The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
American Journal of Surgical Pathology.
35:1062-1068.
2011
|
|
| 2011
|
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients
2011
|
|
| 2011
|
The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
American Journal of Surgical Pathology.
35:608-614.
2011
|
|
| 2011
|
Prostate cancer staging and grading at radical prostatectomy over time.
Advances in Anatomic Pathology.
18:159-164.
2011
|
|
| 2011
|
Single focus prostate cancer: Pathological features and erg fusion status.
Investigative urology.
185:489-494.
2011
|
|
| 2011
|
Adenomatoid tumour of the adrenal gland in a patient with germline SDHD mutation: A case report and review of the literature.
Pathology.
43:495-498.
2011
|
|
| 2011
|
International society of urological pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced disease.
Modern Pathology.
24:26-38.
2011
|
|
| 2011
|
Pathology update for urologists..
Prostate Cancer.
2011:183761.
2011
|
|
| 2011
|
The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy.
International Brazilian Journal of Urology.
37:123.
2011
|
|
| 2010
|
Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidney.
American Journal of Surgical Pathology.
34:1608-1621.
2010
|
|
| 2010
|
ERG rearrangement is present in a subset of transition zone prostatic tumors.
Modern Pathology.
23:1499-1506.
2010
|
|
| 2010
|
Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
Investigative urology.
184:1958-1962.
2010
|
|
| 2010
|
Renal cell carcinomas with intratumoral fat and concomitant angiomyolipoma: Potential pitfalls in staging and diagnosis.
American Journal of Clinical Pathology.
134:807-812.
2010
|
|
| 2010
|
Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: A correlative study and implications for focal therapy.
Urology.
76:682-687.
2010
|
|
| 2010
|
Reply.
Urology.
76:687-688.
2010
|
|
| 2010
|
Staging prostate cancer and its relationship to prognosis.
Current Diagnostic Pathology.
16:432-438.
2010
|
|
| 2010
|
The Epstein Criteria Predict for Organ-Confined But Not Insignificant Disease and a High Likelihood of Cure at Radical Prostatectomy.
European Urology.
58:90-95.
2010
|
|
| 2010
|
Importance of Additional "Extreme" Anterior Apical Needle Biopsies in the Initial Detection of Prostate Cancer.
Urology.
75:1034-1039.
2010
|
|
| 2010
|
Atypical cribriform lesions of the prostate: Relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
American Journal of Surgical Pathology.
34:470-477.
2010
|
|
| 2010
|
ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
American Journal of Surgical Pathology.
34:478-485.
2010
|
|
| 2010
|
Third prize: Synchronized real-time ultrasonography and three-dimensional computed tomography scan navigation during percutaneous renal cryoablation in a porcine model
2010
|
|
| 2010
|
Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: Implications for clinical management.
BJU International.
105:476-480.
2010
|
|
| 2010
|
Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.
Pathology.
42:334-338.
2010
|
|
| 2010
|
Editorial Comment.
Investigative urology.
183:157.
2010
|
|
| 2009
|
Are prostate needle biopsies predictive of the laterality of significant cancer and positive surgical margins?.
BJU International.
104:1599-1603.
2009
|
|
| 2009
|
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classification.
American Journal of Surgical Pathology.
33:1840-1849.
2009
|
|
| 2009
|
KTP Laser Nerve Sparing Radical Prostatectomy: Comparison of Ultrasonic and Cold Scissor Dissection on Cavernous Nerve Function.
Investigative urology.
181:2760-2766.
2009
|
|
| 2009
|
Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy.
Investigative urology.
181:1672-1677.
2009
|
|
| 2009
|
Renal angiomyolipoma: Clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association.
American Journal of Surgical Pathology.
33:289-297.
2009
|
|
| 2009
|
Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: Molecular and histologic evidence.
American Journal of Surgical Pathology.
33:72-80.
2009
|
|
| 2009
|
Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor.
Modern Pathology.
22:385-392.
2009
|
|
| 2008
|
Low Testosterone and Risk of Biochemical Recurrence and Poorly Differentiated Prostate Cancer at Radical Prostatectomy.
Urology.
72:1240-1245.
2008
|
|
| 2008
|
Prostatic Adenocarcinoma, Prostatic Intraepithelial Neoplasia, and Intraductal Carcinoma.
Surgical Pathology Clinics.
1:43-75.
2008
|
|
| 2008
|
Urothelial Carcinoma and its Variants.
Surgical Pathology Clinics.
1:159-209.
2008
|
|
| 2008
|
Pathologic characteristics of solitary small renal masses: Can they be predicted by preoperative clinical parameters?.
American Journal of Clinical Pathology.
130:560-564.
2008
|
|
| 2008
|
Laser robotically assisted nerve-sparing radical prostatectomy: A pilot study of technical feasibility in the canine model.
BJU International.
102:598-602.
2008
|
|
| 2008
|
The distinction of bronchogenic cyst from metastatic testicular teratoma: A light microscopic and immunohistochemical study.
American Journal of Clinical Pathology.
130:265-273.
2008
|
|
| 2008
|
Adult Cystic Nephroma and Mixed Epithelial and Stromal Tumor of the Kidney: Clinical, Radiographic, and Pathologic Characteristics.
Urology.
71:1142-1148.
2008
|
|
| 2008
|
Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.
Clinical Cancer Research.
14:3052-3059.
2008
|
|
| 2008
|
Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate Biopsy.
Investigative urology.
179:1746-1750.
2008
|
|
| 2008
|
Pathological Aggressiveness of Prostatic Carcinomas Related to RNASEL R462Q Allelic Variants.
Investigative urology.
179:1344-1348.
2008
|
|
| 2008
|
Renal cell carcinomas with papillae.
Revista Española de Patología.
41:99-107.
2008
|
|
| 2008
|
Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading.
Investigative urology.
179:896-900.
2008
|
|
| 2007
|
Parasagittal biopsies are more important as part of an initial biopsy strategy than as part of a repeat biopsy strategy: Observations from a unique population.
Prostate Cancer and Prostatic Diseases.
10:352-355.
2007
|
|
| 2007
|
Pathological evidence of necrosis in recurrent renal mass following treatment with sunitinib.
International Journal of Urology.
14:1095-1097.
2007
|
|
| 2007
|
Pathologic Stage Migration Has Slowed in the Late PSA Era.
Urology.
70:839-842.
2007
|
|
| 2007
|
Renal neuroendocrine tumours: A clinicopathological study.
BJU International.
100:1030-1035.
2007
|
|
| 2007
|
Preoperative PSA Is Still Predictive of Cancer Volume and Grade in Late PSA Era.
Urology.
70:711-716.
2007
|
|
| 2007
|
Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic study.
Cancer.
110:1248-1254.
2007
|
|
| 2007
|
Tumor Volume Does Not Predict for Biochemical Recurrence After Radical Prostatectomy in Patients with Surgical Gleason Score 6 or Less Prostate Cancer.
Urology.
70:294-298.
2007
|
|
| 2007
|
Erratum: A working group classification of focal prostate atrophy lesions (American Journal of Surgical Pathology (2006) 30, (1281-1291)).
American Journal of Surgical Pathology.
31:652.
2007
|
|
| 2007
|
The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
BJU International.
99:770-774.
2007
|
|
| 2007
|
Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas.
Archives of Pathology and Laboratory Medicine.
131:122-125.
2007
|
|
| 2007
|
The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: A call for standardized methods for immunohistochemical evaluation.
Clinical Genitourinary Cancer.
5:264-270.
2007
|
|
| 2006
|
Erratum: A working group classification of focal prostate atrophy lesions (American Journal of Surgical Pathology (2006) 30 (1281-1291)).
American Journal of Surgical Pathology.
30:1489.
2006
|
|
| 2006
|
A working group classification of focal prostate atrophy lesions.
American Journal of Surgical Pathology.
30:1281-1291.
2006
|
|
| 2006
|
Mucinous adenocarcinoma of the prostate does not confer poor prognosis.
Urology.
68:825-830.
2006
|
|
| 2006
|
Prostate basal cell lesions can be negative for basal cell keratins: A diagnostic pitfall.
Cellular Oncology.
28:125-129.
2006
|
|
| 2006
|
Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: Impact on surgical margins.
Investigative urology.
175:1304-1310.
2006
|
|
| 2006
|
Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
PLoS Pathogens.
2:0211-0225.
2006
|
|
| 2006
|
Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma.
Modern Pathology.
19:392-398.
2006
|
|
| 2006
|
Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.
Investigative urology.
175:485-488.
2006
|
|
| 2006
|
Non-small cell lung carcinoma metastatic to the kidney.
2006
|
|
| 2005
|
Laparoscopic partial nephrectomy for cystic masses.
Investigative urology.
174:614-619.
2005
|
|
| 2005
|
Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy.
Urology.
66:881.e7-881.e9.
2005
|
|
| 2005
|
Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf model.
Investigative urology.
174:1110-1114.
2005
|
|
| 2005
|
The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
Clinics in Laboratory Medicine.
25:247-257.
2005
|
|
| 2005
|
Water jet assisted laparoscopic partial nephrectomy without hilar clamping in the calf model.
Investigative urology.
174:317-321.
2005
|
|
| 2004
|
ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
American Journal of Surgical Pathology.
28:1609-1614.
2004
|
|
| 2004
|
Urothelial papilloma of the bladder: A review of 34 de novo cases.
American Journal of Surgical Pathology.
28:1615-1620.
2004
|
|
| 2004
|
Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes.
2004
|
|
| 2004
|
Continuing trends in pathological stage migration in radical prostatectomy specimens.
Urologic Oncology: seminars and original investigations.
22:300-306.
2004
|
|
| 2004
|
Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer.
Urology.
63:1138-1142.
2004
|
|
| 2004
|
The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy Specimens.
American Journal of Surgical Pathology.
28:394-398.
2004
|
|
| 2004
|
Laparoscopic extended pelvic lymphadenectomy for bladder cancer: Technique and initial outcomes.
Investigative urology.
172:1809-1812.
2004
|
|
| 2003
|
Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy..
American Journal of Surgical Pathology.
27:1128-1133.
2003
|
|
| 2003
|
α-methylacyl-CoA racemase: A variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
American Journal of Surgical Pathology.
27:1128-1133.
2003
|
|
| 2003
|
Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: Duration of atypia and relation to type of radiotherapy.
American Journal of Surgical Pathology.
27:206-212.
2003
|
|
| 2003
|
Threshold for Diagnosing Prostate Cancer over Time.
Human Pathology.
34:1116-1118.
2003
|
|
| 2002
|
Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age
2002
|
|
| 1999
|
Demonstrability of the glycoprotein A-80 in postradiation prostatic carcinoma.
Human Pathology.
30:1474-1478.
1999
|
|
| 1998
|
Mitogen-activated protein kinases and apoptosis in PIN
1998
|
|
| 1998
|
Automated in situ hybridization: Diagnostic and research applications.
Applied Immunohistochemistry and Molecular Morphology.
7:69-75.
1998
|
|
| 1997
|
Heterogeneity of androgen receptor content in advanced prostate cancer.
Modern Pathology.
10:839-845.
1997
|
|
| 1997
|
The cell cycle inhibitor p27 is an independent prognostic marker in small (T(1a,b)) invasive breast carcinomas.
Cancer Research.
57:1259-1263.
1997
|
|
| 1997
|
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Laboratory Investigation.
76:37-51.
1997
|
|
| 1996
|
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.
American Journal of Pathology.
149:1553-1564.
1996
|
|
| 1996
|
Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma
1996
|
|
| 1996
|
Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
Laboratory Investigation.
75:361-370.
1996
|
|
| 1996
|
Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia
1996
|
|
| 1996
|
Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma.
1996
|
|
| 1996
|
Molecular events in the early phases of prostate carcinogenesis.
European Urology.
30:167-176.
1996
|
|
| 1995
|
Apoptotic Bodies in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma Following Total Androgen Ablation
1995
|
|
| 1994
|
Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma
1994
|
|
| 1994
|
Morphometrically assisted grading of astrocytomas.
Cellular Oncology.
16:351-356.
1994
|
|
| 1994
|
Quantitative evaluation of nucleolar features on cytologic material in brain tumor diagnosis.
Clinical Neuropathology.
13:323-328.
1994
|
|
| 1993
|
Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN)
1993
|
|
| 1993
|
Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.
Virchows Archiv. A, Pathological anatomy and histopathology.
423:351-357.
1993
|
|
| 1993
|
Prostatic intra-epithelial neoplasia: Expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei.
Virchows Archiv. A, Pathological anatomy and histopathology.
422:185-192.
1993
|
|
| 1993
|
Computed cell cycle and DNA histogram analyses in image cytometry in breast cancer
1993
|
|
| 1993
|
Proliferating Cell Nuclear Antigen (PCNA) evaluation in the diagnostic quantitative pathology of cribriform adenocarcinoma of the prostate
1993
|
|
| 1993
|
Proliferating cell nuclear antigen (PCNA) in prostatic invasive adenocarcinoma. Is the proliferation state in the marginal zone of the tumour higher than in the central part?
1993
|
|
| 1993
|
Prostatic Intra-epithelial Neoplasia: Qualitative and Quantitative Analyses of the Blood Capillary Architecture on Thin Tissue Sections
1993
|
|
| 1993
|
Prostatic Invasive Adenocarcinoma: Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on the Expression and Location of Proliferating Cell Nuclear Antigen (PCNA)
1993
|
|
| 1992
|
Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN).
Journal of Cellular Biochemistry.
50:47-53.
1992
|
|
| 1992
|
Quantitative analysis of quadriceps muscle biopsy in systemic sclerosis
1992
|
|
| 1991
|
Quantitative analysis of nucleolar margination in diagnostic cytopathology.
Virchows Archiv. A, Pathological anatomy and histopathology.
419:505-512.
1991
|
|
